Clinical Trials Directory

Trials / Completed

CompletedNCT04243174

The Use of Short SMS Messaging With Type 2 Diabetes (T2DM)

The Use of Mobile Phone Messaging as a Behavioural Intervention to Increase Physical Activity in Adults With T2DM in Saudi Arabia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Physical activity (PA) can play a vital and an independent role in type 2 diabetes (T2DM) management care. Health research studies have shown evidence that PA can improve glycaemic control and glucose levels. PA is first line of self-care management recommended to patients with T2DM and most patients fail to perform the regular PA. It is always important for health providers to find better methods in encouraging and incentivizing PA in T2DM patients. Mobile phone messaging-based interventions have been shown to strengthen the delivery of health information and self-care management programs.

Detailed description

Studies have employed this as a tool for promoting T2DM self-care management interventions such as physical activity, glucose monitoring, medication adherence and nutrition. Despite the increasing number of these interventions globally, the effectiveness of mobile phone messaging-based interventions in Saudi Arabia context remains inconclusive and inconsistent. There is limited research conducted in this region. Therefore, there is a need for more studies to show evidence to ascertain the effectiveness of using mobile phone messaging to promote PA in T2DM patients in the context of Saudi Arabia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMS MessagingPatients with type 2 diabetes will be recruited and will start receiving short SMS messages about physical activity, encouraging them to be more active and help them to build a healthy life style routine.

Timeline

Start date
2020-01-23
Primary completion
2020-03-01
Completion
2020-03-30
First posted
2020-01-28
Last updated
2021-08-27

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT04243174. Inclusion in this directory is not an endorsement.